Related Experiment Video
Updated: Mar 6, 2026

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
Published on: February 10, 2015
The role of bile acid-activated receptor TGR5 in inflammation and liver diseases
Hongyan Xiang1, Huanyu Xiang1, Shuyun Wang1
1Department of Geriatrics, Chongqing General Hospital, Chongqing University, Chongqing, China.
Abstract:
Takeda G-protein-coupled receptor 5 (TGR5), a bile acid receptor, has been recognized as an important signal molecule with roles extending far beyond bile acid homeostasis. Its activation has been shown to ameliorate metabolic disorders and suppress inflammatory responses through diverse mechanisms. Expressed widely in both parenchymal and non-parenchymal cells of the liver, TGR5 plays a central role in hepatic physiology and disease. This review consolidates current evidence on the involvement of TGR5 in various liver pathologies, including metabolic dysfunction-associated steatohepatitis, cholestatic diseases, liver fibrosis, and hepatocellular carcinoma. Additionally, we summarize the regulatory functions of TGR5 in immune cells and inflammatory signaling pathways. We emphasize TGR5 as a promising therapeutic target for a range of chronic liver diseases, given its pivotal role in modulating inflammation and metabolism. Future research should focus on developing tissue-specific TGR5 agonists to enhance therapeutic efficacy and reduce systemic side effects, as well as elucidating its context-dependent dual roles in hepatocarcinogenesis to ensure safe clinical application.
Insights
Takeda G-protein-coupled receptor 5 (TGR5) is a bile acid receptor crucial for liver health. Targeting TGR5 shows promise for treating chronic liver diseases by modulating inflammation and metabolism.
Area of Science:
- Hepatology and Gastroenterology
- Immunology
- Metabolic Diseases
Background:
- Takeda G-protein-coupled receptor 5 (TGR5) is a bile acid receptor with functions beyond bile acid homeostasis.
- TGR5 activation influences metabolic disorders and inflammatory responses via multiple mechanisms.
- The receptor is widely expressed in liver cells, highlighting its central role in hepatic physiology and pathology.
Purpose of the Study:
- To review the involvement of TGR5 in diverse liver diseases.
- To summarize TGR5's regulatory roles in immune cells and inflammatory pathways.
- To evaluate TGR5 as a therapeutic target for chronic liver conditions.
Main Methods:
- Literature review consolidating current evidence on TGR5 in liver pathologies.
- Summary of TGR5's regulatory functions in immune and inflammatory pathways.
- Analysis of TGR5's therapeutic potential and future research directions.
Main Results:
- TGR5 is implicated in metabolic dysfunction-associated steatohepatitis, cholestatic diseases, liver fibrosis, and hepatocellular carcinoma.
- TGR5 modulates immune cell function and inflammatory signaling.
- The receptor plays a pivotal role in regulating liver metabolism and inflammation.
Conclusions:
- TGR5 is a promising therapeutic target for chronic liver diseases due to its role in inflammation and metabolism.
- Future research should focus on developing tissue-specific TGR5 agonists for enhanced efficacy and reduced side effects.
- Further elucidation of TGR5's dual roles in hepatocarcinogenesis is necessary for safe clinical application.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...

